Good question Outgoing. I think the CEO has given some information on it in his presentation but it is a bit beyond my medical knowledge to try to explain -
I am guessing that part of the issue also is that the company is much further advanced towards the clinic with DX1 which will probably add value for shareholders a bit earlier. Just my take on it.
Looking forward to the next 12 months with great excitement., page-25
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.34M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.6¢ | $6.723K | 1.120M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 9665158 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 597624 | 2 |
View Market Depth
| Last trade - 14.44pm 23/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |